[Therapy of hypertension. Lasting organ protection moves into the foreground].
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000517:prevention & control*; D017257:Ramipril / Q000627:therapeutic use; D044140:Receptor, Angiotensin, Type 1 / Q000187:drug effects*; D020521:Stroke / Q000517:prevention & control*; D000077333:Telmisartan; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D044140:Receptor, Angiotensin, Type 1; D017257:Ramipril; D000077333:Telmisartan